Grover P. Miller

3.5k total citations
97 papers, 2.8k citations indexed

About

Grover P. Miller is a scholar working on Pharmacology, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Grover P. Miller has authored 97 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Pharmacology, 39 papers in Molecular Biology and 20 papers in Computational Theory and Mathematics. Recurrent topics in Grover P. Miller's work include Pharmacogenetics and Drug Metabolism (56 papers), Computational Drug Discovery Methods (20 papers) and Eicosanoids and Hypertension Pharmacology (16 papers). Grover P. Miller is often cited by papers focused on Pharmacogenetics and Drug Metabolism (56 papers), Computational Drug Discovery Methods (20 papers) and Eicosanoids and Hypertension Pharmacology (16 papers). Grover P. Miller collaborates with scholars based in United States, Netherlands and South Korea. Grover P. Miller's co-authors include F. Peter Guengerich, S. Joshua Swamidass, Tyler B. Hughes, Eric T. Kool, Natilie Hosea, Stephen J. Benkovic, Chul‐Ho Yun, Jessica H. Hartman, Drew R. Jones and Stephen J. Benkovic and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Grover P. Miller

96 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Grover P. Miller United States	31	1.3k	1.1k	466	409	408	97	2.8k
Irina F. Sevrioukova United States	33	1.8k 1.3×	1.6k 1.5×	566 1.2×	254 0.6×	569 1.4×	74	3.4k
C.D. Stout United States	26	1.6k 1.2×	1.4k 1.3×	614 1.3×	380 0.9×	645 1.6×	49	3.5k
Emily E. Scott United States	34	1.7k 1.3×	2.1k 1.9×	759 1.6×	243 0.6×	760 1.9×	86	3.9k
Dijana Matak‐Vinković United Kingdom	24	1.9k 1.5×	976 0.9×	488 1.0×	199 0.5×	556 1.4×	41	3.2k
Pamela A. Williams United Kingdom	27	1.8k 1.4×	1.5k 1.4×	771 1.7×	220 0.5×	696 1.7×	49	3.9k
Rakesh Paul India	8	1.1k 0.9×	1.1k 1.0×	217 0.5×	303 0.7×	511 1.3×	11	2.6k
Sergey A. Usanov Belarus	24	1.0k 0.8×	1.0k 1.0×	269 0.6×	164 0.4×	316 0.8×	137	2.6k
Deepak Dalvie United States	33	1.7k 1.3×	1.5k 1.4×	607 1.3×	831 2.0×	609 1.5×	76	4.0k
Flemming Steen Jørgensen Denmark	36	1.7k 1.3×	411 0.4×	697 1.5×	367 0.9×	322 0.8×	140	3.3k
Sandeep Modi United Kingdom	26	1.2k 0.9×	987 0.9×	527 1.1×	306 0.7×	379 0.9×	67	2.5k

Countries citing papers authored by Grover P. Miller

Since Specialization

Citations

This map shows the geographic impact of Grover P. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grover P. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grover P. Miller more than expected).

Fields of papers citing papers by Grover P. Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grover P. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grover P. Miller. The network helps show where Grover P. Miller may publish in the future.

Co-authorship network of co-authors of Grover P. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Grover P. Miller. A scholar is included among the top collaborators of Grover P. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grover P. Miller. Grover P. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jones, Aaron P., Ali S. Taha, & Grover P. Miller. (2025). The resurgence of synthetic cannabinoid receptor agonists as adulterants in the Era of Cannabis legalization: Lessons from prior epidemics and clinical implications. Neuroscience & Biobehavioral Reviews. 170. 106043–106043. 1 indexed citations

McGill, Mitchell R., et al.. (2023). The Role of Cytochrome P450 3A4-Mediated Metabolism in Sorafenib and Lapatinib Hepatotoxicity. SHILAP Revista de lepidopterología. 3(2). 310–321. 8 indexed citations

Wang, Zeyuan, William E. Fantegrossi, Swati Nagar, et al.. (2022). Similar 5F-APINACA Metabolism between CD-1 Mouse and Human Liver Microsomes Involves Different P450 Cytochromes. Metabolites. 12(8). 773–773. 1 indexed citations

Khojasteh, S. Cyrus, Upendra A. Argikar, James P. Driscoll, et al.. (2021). Novel advances in biotransformation and bioactivation research – 2020 year in review. Drug Metabolism Reviews. 53(3). 384–433. 6 indexed citations

Cui, Huarui, Ke Shi, Hideki Aihara, et al.. (2021). 4-Methyl-1,2,3-Triazoles as N-Acetyl-Lysine Mimics Afford Potent BET Bromodomain Inhibitors with Improved Selectivity. Journal of Medicinal Chemistry. 64(14). 10497–10511. 28 indexed citations

Libardoni, Mark, Grover P. Miller, Kelly E. Miller, et al.. (2020). Experimental Coupling of a MEMS Gas Chromatograph and a Mass Spectrometer for Organic Analysis in Space Environments. ACS Earth and Space Chemistry. 4(10). 1718–1729. 14 indexed citations

Hartman, Jessica H., Grover P. Miller, Antonio Andrés, et al.. (2017). 1,3-Butadiene-induced mitochondrial dysfunction is correlated with mitochondrial CYP2E1 activity in Collaborative Cross mice. Toxicology. 378. 114–124. 21 indexed citations

Nshimiyimana, Robert, et al.. (2017). Stereospecific Metabolism of R- and S-Warfarin by Human Hepatic Cytosolic Reductases. Drug Metabolism and Disposition. 45(9). 1000–1007. 9 indexed citations

Hartman, Jessica H., et al.. (2014). Structural basis for cooperative binding of azoles to CYP2E1 as interpreted through guided molecular dynamics simulations. Journal of Molecular Graphics and Modelling. 56. 43–52. 15 indexed citations

10.

Hartman, Jessica H., Gunnar Boysen, & Grover P. Miller. (2013). Cooperative effects for CYP2E1 differ between styrene and its metabolites. Xenobiotica. 43(9). 755–764. 10 indexed citations

11.

Hartman, Jessica H., Gunnar Boysen, & Grover P. Miller. (2012). CYP2E1 Metabolism of Styrene Involves Allostery. Drug Metabolism and Disposition. 40(10). 1976–1983. 22 indexed citations

12.

Jones, Drew R., Gunnar Boysen, & Grover P. Miller. (2011). Novel multi-mode ultra performance liquid chromatography–tandem mass spectrometry assay for profiling enantiomeric hydroxywarfarins and warfarin in human plasma. Journal of Chromatography A. 1 indexed citations

13.

Jones, Drew R., Jeffery H. Moran, & Grover P. Miller. (2010). Warfarin and UDP-glucuronosyltransferases: writing a new chapter of metabolism. Drug Metabolism Reviews. 42(1). 55–61. 25 indexed citations

14.

Jones, Drew R., So Young Kim, Gunnar Boysen, Chul‐Ho Yun, & Grover P. Miller. (2010). Contribution of Three CYP3A Isoforms to Metabolism of R- and S-Warfarin. Drug Metabolism Letters. 4(4). 213–219. 14 indexed citations

15.

Miller, Grover P.. (2008). Advances in the interpretation and prediction of CYP2E1 metabolism from a biochemical perspective. Expert Opinion on Drug Metabolism & Toxicology. 4(8). 1053–1064. 30 indexed citations

16.

Miller, Grover P., Adam P. Silverman, & Eric T. Kool. (2007). New, stronger nucleophiles for nucleic acid-templated chemistry: Synthesis and application in fluorescence detection of cellular RNA. Bioorganic & Medicinal Chemistry. 16(1). 56–64. 32 indexed citations

17.

Tackett, Alan J., et al.. (2006). CYP2E1 active site residues in substrate recognition sequence 5 identified by photoaffinity labeling and homology modeling. Archives of Biochemistry and Biophysics. 459(1). 59–69. 21 indexed citations

18.

Kool, Eric T. & Grover P. Miller. (2003). 5′‐Iodination of Solid‐Phase‐Linked Oligodeoxyribonucleotides. Current Protocols in Nucleic Acid Chemistry. 14(1). Unit 4.19–Unit 4.19. 1 indexed citations

19.

Miller, Grover P., Daphne Wahnon, & Stephen J. Benkovic. (2001). Interloop Contacts Modulate Ligand Cycling during Catalysis byEscherichia coliDihydrofolate Reductase. Biochemistry. 40(4). 867–875. 45 indexed citations

20.

Liotta, Louis J., Patricia A. Benkovic, Grover P. Miller, & Stephen J. Benkovic. (1993). Catalytic antibody for imide hydrolysis featuring a bifunctional transition-state mimic. Journal of the American Chemical Society. 115(1). 350–351. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact